News for hackers. Stuff that matters.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by refurb on Wednesday September 22, 2021 @09:04PM (#28624077)
The FDA does have that option and is doing it for this drug. It’s called a “National Coverage Determination”

https://www.cms.gov/newsroom/press-releases/cms-opens-nation...

"Today, the Centers for Medicare & Medicaid Services (CMS) is opening a National Coverage Determination (NCD) analysis, a process that will allow the agency to carefully review and determine whether Medicare will establish a national Medicare coverage policy for monoclonal antibodies targeting amyloid for the treatment of Alzheimer’s disease."

There are no comments on this comment yet.